2017
DOI: 10.1016/j.carbpol.2017.04.028
|View full text |Cite
|
Sign up to set email alerts
|

Injectable hyaluronic acid/poly(ethylene glycol) hydrogels crosslinked via strain-promoted azide-alkyne cycloaddition click reaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
60
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 85 publications
(63 citation statements)
references
References 42 publications
3
60
0
Order By: Relevance
“…Cells cultured in the hybrid hydrogel exhibit higher viability and proliferation rate than those cultured in pure PAM hydrogel (Han et al, 2017 ). What's more, HA/PEG hybrid hydrogel prepared via the SPAAC crosslinking shows excellent biocompatibility (Fu et al, 2017 ), which may be due to the fact that HA can bond to some receptors on cell membrane to affect both chondrocyte survival pathway and apoptotic pathway (Knudson and Knudson, 2004 ).…”
Section: Control Of Chemical Propertiesmentioning
confidence: 99%
“…Cells cultured in the hybrid hydrogel exhibit higher viability and proliferation rate than those cultured in pure PAM hydrogel (Han et al, 2017 ). What's more, HA/PEG hybrid hydrogel prepared via the SPAAC crosslinking shows excellent biocompatibility (Fu et al, 2017 ), which may be due to the fact that HA can bond to some receptors on cell membrane to affect both chondrocyte survival pathway and apoptotic pathway (Knudson and Knudson, 2004 ).…”
Section: Control Of Chemical Propertiesmentioning
confidence: 99%
“…PEG is biocompatible and biodegradable [134,180]. Modification of crosslinkers used to crosslink acrylate terminated PEG can introduce degradation profiles, for example including 3 wt% of cyclooctyne-hyaluronic acid results in complete degradation in 46 days in pH 9, or 10 days in pH 7.4 with hyaluronidase (HAse) [181]. Concurrently, a study on degradation was reported using rhodamine B mixed with PEGMA as a model drug and its release kinetics shown to be influenced by different device designs, material densities, and porosities [179].…”
Section: Biocompatibility Biodegradability and Bioactivitymentioning
confidence: 99%
“…[119] One representativer eaction, copperfree azide-alkyne cycloaddition, hasb een employed for encapsulatingc ells using PEG, protein, and hyaluronic acid derivatives ( Figure 3g). [165][166][167][168][169][170][171][172][173][174][175][176] Structurally varied cyclooctyne derivatives that take into account reactionk inetics, hydrophilicity, and synthetic routes have been developed. For example, it has been reported that dibenzylcyclooctynes and bicyclononynes more rapidlyp roduce cross-linked hydrogels than difluorinated cyclooctynes.…”
Section: Ionotropic Encapsulation By Microfluidicdevicementioning
confidence: 99%